Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("DILAZEP")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 137

  • Page / 6
Export

Selection :

  • and

Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytesDEGUCHI, H; TAKEYA, H; WADA, H et al.Blood. 1997, Vol 90, Num 6, pp 2345-2356, issn 0006-4971Article

Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazepSENGUPTA, Dhruba J; UNADKAT, Jashvant D.Biochemical pharmacology. 2004, Vol 67, Num 3, pp 453-458, issn 0006-2952, 6 p.Article

Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamoleSHURALYOVA, Irina; TAJMIR, Panteha; BILAN, Philip J et al.American journal of physiology. Heart and circulatory physiology. 2004, Vol 55, Num 2, pp H627-H632, issn 0363-6135Article

Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 ReplicationPASSER, Brent J; CHEEMA, Tooba; QIANJUN LI et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 10, pp 3890-3895, issn 0008-5472, 6 p.Article

Dilazep hydrochloride, an antiplatelet drug, prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty ratsYAMAGISHI, S; KOGA, K; INAGAKI, Y et al.Drugs under experimental and clinical research. 2002, Vol 28, Num 6, pp 221-227, issn 0378-6501, 7 p.Article

Effet thérapeutique du dilazep dans la démenceKOBAYASHI, K.Yakuri to chiryo. 1987, Vol 15, Num 1, pp 359-369, issn 0386-3603Article

Effect of dilazep hydrochloride on the immunohistopathology of IgA nephropathy in ddY miceHAYASHI, Takeshi; KANEKO, Shougo; NGUYEN TAT THANG et al.Nephron. 2000, Vol 86, Num 3, pp 327-332, issn 0028-2766Article

Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathyNAKAMURA, T; USHIYAMA, C; SHIMADA, N et al.Diabetes care. 2000, Vol 23, Num 8, pp 1168-1171, issn 0149-5992Article

Cross over placebo control trial of dilazep in beta-thalassemia/hemoglobin E patientsOPARTKIATTIKUL, N; SUKPANICHNANT, S; FUNAHARA, Y et al.Southeast Asian journal of tropical medicine and public health. 1999, Vol 30, Num 2, pp 307-310, issn 0125-1562Article

K-7259 : A cardioprotective derivative of dilazepABIKO, Y; HASHIZUME, H; HARA, A et al.Cardiovascular drug reviews (Print). 1997, Vol 15, Num 4, pp 335-353, issn 0897-5957Article

Inhibitory effect of dilazep hydrochloride on the formation of advanced glycation end productsTANAKA, Y; INOUE, K; SHIMADA, S et al.Current therapeutic research. 2000, Vol 61, Num 4, pp 191-198, issn 0011-393XArticle

ISOTOPENTECHNISCHE UNTERSUCHUNGEN ZUR PHARMAKOKINETIC UND ZUM METABOLISMUS VON DILAZEP AN DER RATTE = RECHERCHES PAR LES TECHNIQUES ISOTOPIQUES SUR LA PHARMACOCINETIQUE ET LE METABOLISME DU DILAZEP CHEZ LE RATSCHAUMLOEFFEL E; CLAUSNITZER M.1972; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1972; VOL. 22; NO 10; PP. 1643-1650; ABS. ANGL.; BIBL. 5REF.Serial Issue

ANTI-ARRHYTHMIC ACTION OF DILAZEP. ACTION ON EXPERIMENTAL ARRHYTHMIAS INDUCED BY G-STROPHANTHIN (OUABAIN), EPINEPHRINE AND ACONITINE = ACTION ANTI-ARYTHMIQUE DU DILAZEP. ACTION SUR LES ARYTHMIES EXPERIMENTALES INDUITES PAR LA G-STROPHANTHINE (OUABAINE), L'ADRENALINE ET L'ACONITINESANO N; KAWADA M; FUKUTOMI Y et al.1974; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1974; VOL. 24; NO 11A; PP. 1893-1898; ABS. ALLEM.; BIBL. 18REF.Article

Etude clinique du Comelian® dans les troubles de la circulation vasculaire périphériqueSASAKI, T.Yakuri to chiryo. 1988, Vol 16, Num 4, pp 369-372, issn 0386-3603Article

Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cellsARCHER, Richard G. E; PITELKA, Vaclav; HAMMOND, James R et al.British journal of pharmacology. 2004, Vol 143, Num 1, pp 202-214, issn 0007-1188, 13 p.Article

Elevation of plasma adenosine levels may attenuate the severity of chronic Heart failureKITAKAZE, M; MINAMINO, T; NODE, K et al.Cardiovascular drugs and therapy. 1998, Vol 12, Num 3, pp 307-309, issn 0920-3206Article

Protective effects of dilazep and its derivative K-7259 on the haemolysis induced by amphiphiles in rat erythrocytesHARA, A; HAYASE, N; HASHIZUME, H et al.Journal of pharmacy and pharmacology. 1997, Vol 49, Num 8, pp 806-811, issn 0022-3573Article

A double-blind placebo control trial of Dilazep in β-thalassemia/hemoglobin E patientsOPARTKIATTIKUL, N; SUKPANICHNANT, S; WANACHIWANAWIN, W et al.Southeast Asian journal of tropical medicine and public health. 1997, Vol 28, pp 167-171, issn 0125-1562, SUP3Conference Paper

STATISTISCHE AUSWERTUNG EINER GEMEINSCHAFTSSTUDIE ZUR UNTERSUCHUNG DER WIRKSAMKEIT DES KORONARTRAINERS DILAZEP BEI ISCHAEMISCHEN HERZERKRANKUNGEN. III. EINFLUSS VON THERAPIEDAUER UND KOMEDIKATION AUF DAS BEHANDLUNGSERGEBNIS. NEBENWIRKUNGEN UND THERAPIEABBRUECHE = EVALUATION STATISTIQUE D'UNE ETUDE COOPERATIVE SUR L'EFFICACITE DU CORONARO-STIMULANT DILAZEP DANS L'INSUFFISANCE CARDIAQUE ISCHEMIQUE. III. INFLUENCE DE LA DUREE DU TRAITEMENT ET DES MEDICATIONS ASSOCIEES SUR LE RESULTAT THERAPEUTIQUE. EFFETS SECONDAIRES ET INTERRUPTION DU TRAITEMENTSCHNEIDER B; FELDMANN U; VON BRACHEL H et al.1974; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1974; VOL. 24; NO 11A; PP. 1873-1879; ABS. ANGL.; BIBL. 6REF.Article

Dipyridamole and dilazep suppress oxygen radicals in puromycin aminonucleoside nephrosis rats. CommentaryNAKAMURA, K; KOJIMA, K; RABELINK, T. J et al.European journal of clinical investigation. 1998, Vol 28, Num 11, pp 877-885, issn 0014-2972Article

Effect of dilazep dihydrochloride on urinary albumin excretion in patients with autosomal dominant polycystic kidney diseaseNAKAMURA, Tsukasa; USHIYAMA, Chifuyu; TAKAHASHI, Yutaka et al.Nephron. 2001, Vol 88, Num 1, pp 80-82, issn 0028-2766Article

High-performance liquid chromatographic assay of dilazep in plasma after solid-phase extractionGUMIENICZEK, A; PRZYBOROWSKI, L.Journal of pharmaceutical and biomedical analysis. 1997, Vol 15, Num 7, pp 997-1000, issn 0731-7085Article

EFFECT OF DILAZEP ON SHAPE CHANGE OF HUMAN ERYTHROCYTE IN BLOOD STORED OVER A PERIOD OF 42 DAYSFUJISAWA Y; ABIKO Y.1981; ARZNEIM-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 9; PP. 1462-1468; ABS. GER; BIBL. 26 REF.Article

STATISTISCHE AUSWERTUNG EINER GEMEINSCHAFTSSTUDIE ZUR UNTERSUCHUNG DER WIRKSAMKEIT DES KORONARTRAINERS DILAZEP BEI ISCHAEMISCHEN HERZERKRANKUNGEN. I. EPIDEMIOLOGISCHE SITUATION DER KORONAREN HERZERKRANKUNGEN = EVALUATION STATISTIQUE D'UNE ETUDE COOPERATIVE SUR L'EFFICACITE DU CORONARO-STIMULANT DILAZEP DANS L'INSUFFISANCE CARDIAQUE ISCHEMIQUE. I. EPIDEMIOLOGIE DES CARDIOPATHIES CORONARIENNESSCHNEIDER B; FELDMANN U; VON BRACHEL H et al.1974; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1974; VOL. 24; NO 11A; PP. 1853-1864; ABS. ANGL.; BIBL. 26REF.Article

TIEREXPERIMENTELLE UNTERSUCHUNGEN ZUR KORONAR- UND KREISLAUFWIRKUNG VON DIPYRIDAMOL, CARBOCHROMEN, HEXOBENDIN, DILAZEP UND GLUKAGON = RECHERCHES EXPERIMENTALES CHEZ L'ANIMAL SUR L'ACTIVITE CORONAIRE ET CIRCULATOIRE DU DIPYRIDAMOLE, DU CARBOCROMENE, DE L'HEXOBENDINE, DU DILAZEP ET DU GLUCAGON1973; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1973; VOL. 23; NO 5; PP. 629-639; ABS. ANGL.; BIBL. 1P.Serial Issue

  • Page / 6